What is Cambridge Cognition Holdings Plc (COG.L)?

Cambridge Cognition Holdings Plc (COG.L) is a stock in the Healthcare sector, Medical - Healthcare Information Services industry. View full analysis on Stocks360.

Cambridge Cognition Holdings Plc (COG.L)

Stock analysis · LSE · Healthcare · Medical - Healthcare Information Services

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.81

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

Cambridge Cognition Holdings Plc (COG.L) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent

Apr 13, 2026

EPS $-0.01 vs est. $-0.01

Missed by $0.01

Proprietary Signals

Signal snapshot temporarily unavailable.

About Cambridge Cognition Holdings Plc

Cambridge Cognition Holdings Plc is a neuroscience technology company focused on developing and globally marketing sophisticated cognitive testing solutions for use in clinical settings. The firm operates internationally, serving clients in the United States, United Kingdom, and European Union, among other regions. Its extensive product portfolio includes CANTAB Recruit, an online platform designed to help pharmaceutical and biotechnology companies efficiently identify and onboard eligible participants for clinical trials, particularly in high-need therapeutic areas such as Alzheimer's disease. For broader pharmaceutical research, CANTAB Connect offers digital cognitive assessment tools applicable across all clinical trial phases (I-IV) and various medical fields. Additionally, the Cognition Kit is a digital health platform that utilizes wearable and smartphone applications to collect data, aiming to boost patient involvement, validate treatment efficacy, and deepen understanding of diseases and individual responses to medication. Other specialized offerings include CANTAB Connect Research, advanced software providing precise digital metrics for cognitive function in brain researc…